Target intelligence / Profile preview

Hemagglutinin Protein of Influenza A Virus (H7 Subtype) (HA (H7))

Target
HA (H7)
Molecular classification
Glycoprotein, Viral Surface Protein, Receptor
01

Overview

The hemagglutinin (HA) protein is a major surface glycoprotein of the Influenza A virus, responsible for binding the virus to host cell receptors and facilitating viral entry. The H7 subtype refers specifically to one of the 18 known HA subtypes found in influenza A viruses. HA mediates attachment of the influenza virus to sialic acid-containing receptors on host cells, initiating infection, and also facilitates fusion between viral and endosomal membranes after endocytosis, allowing release of viral RNA into the host cytoplasm. Avian influenza A viruses with H7 can be either highly pathogenic avian influenza (HPAI) or low pathogenic avian influenza (LPAI). Recent studies show some North American lineage H7N2/H7N3 isolates possess increased affinity for human-like α2–6 SA linkages—an adaptation associated with pandemic potential—and can transmit efficiently between ferrets via direct contact models used as surrogates for human transmission studies.

Other names
H7 HemagglutininInfluenza A H7 HAHA0 (H7 precursor)
02

Biological functions

Viral attachmentMembrane fusionReceptor bindingViral entry
03

Disease associations

Influenza A infectionAvian influenzaConjunctivitisRespiratory failure
04

Safety considerations

Potential for pandemic spreadAntigenic driftAntigenic shiftVariable pathogenicity

Beyond the preview

Go deeper on Hemagglutinin Protein of Influenza A Virus (H7 Subtype) (HA (H7)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin Protein of Influenza A Virus (H7 Subtype) (HA (H7)).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call